Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?

Coccaro N, Anelli L, Zagaria A, Perrone T, Specchia G, Albano F.

Cancers (Basel). 2020 Jan 11;12(1). pii: E185. doi: 10.3390/cancers12010185. Review.

2.

Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia.

Cumbo C, Minervini CF, Orsini P, Anelli L, Zagaria A, Minervini A, Coccaro N, Impera L, Tota G, Parciante E, Conserva MR, Spinelli O, Rambaldi A, Specchia G, Albano F.

Genes (Basel). 2019 Dec 9;10(12). pii: E1026. doi: 10.3390/genes10121026.

3.

RARG Gene Dysregulation in Acute Myeloid Leukemia.

Conserva MR, Redavid I, Anelli L, Zagaria A, Specchia G, Albano F.

Front Mol Biosci. 2019 Oct 24;6:114. doi: 10.3389/fmolb.2019.00114. eCollection 2019. Review.

4.

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment.

Tarantini F, Anelli L, Ingravallo G, Attolico I, Zagaria A, Russo Rossi A, Lospalluti L, Bufano T, Zanframundo G, Maiorano E, Specchia G, Albano F.

Cancer Manag Res. 2019 Aug 26;11:7991-7996. doi: 10.2147/CMAR.S217872. eCollection 2019.

5.

Chemical characterization of pterosaur melanin challenges color inferences in extinct animals.

Pinheiro FL, Prado G, Ito S, Simon JD, Wakamatsu K, Anelli LE, Andrade JAF, Glass K.

Sci Rep. 2019 Nov 4;9(1):15947. doi: 10.1038/s41598-019-52318-y.

6.

A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia.

Coccaro N, Anelli L, Orsini P, Zagaria A, Minervini A, Impera L, Tota G, Minervini CF, Cumbo C, Parciante E, Coserva MR, Attolico I, Specchia G, Albano F.

Cancer Genet. 2019 Nov;239:8-12. doi: 10.1016/j.cancergen.2019.08.003. Epub 2019 Aug 21.

PMID:
31450116
7.

Next-Generation Sequencing in Acute Lymphoblastic Leukemia.

Coccaro N, Anelli L, Zagaria A, Specchia G, Albano F.

Int J Mol Sci. 2019 Jun 15;20(12). pii: E2929. doi: 10.3390/ijms20122929. Review.

8.

The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia.

Conserva MR, Anelli L, Zagaria A, Specchia G, Albano F.

Int J Mol Sci. 2019 Jun 14;20(12). pii: E2921. doi: 10.3390/ijms20122921. Review.

9.

Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.

Orsini P, Impera L, Parciante E, Cumbo C, Minervini CF, Minervini A, Zagaria A, Anelli L, Coccaro N, Casieri P, Tota G, Brunetti C, Ricco A, Carluccio P, Specchia G, Albano F.

Diagn Pathol. 2018 Dec 22;13(1):98. doi: 10.1186/s13000-018-0777-x.

10.

Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia.

Orsini P, Minervini CF, Cumbo C, Anelli L, Zagaria A, Minervini A, Coccaro N, Tota G, Casieri P, Impera L, Parciante E, Brunetti C, Giordano A, Specchia G, Albano F.

Sci Rep. 2018 Aug 7;8(1):11798. doi: 10.1038/s41598-018-30330-y.

11.

Monitoring minimal residual disease by ddPCR in acute lymphoblastic leukemia associated with the FGFR1 gene rearrangement.

Coccaro N, Tota G, Zagaria A, Anelli L, Casieri P, Impera L, Minervini A, Minervini CF, Orsini P, Cumbo C, Parciante E, Delia M, Brunetti C, Specchia G, Albano F.

Int J Lab Hematol. 2018 Dec;40(6):e117-e120. doi: 10.1111/ijlh.12879. Epub 2018 Jun 28. No abstract available.

PMID:
29956473
12.

The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?

Anelli L, Zagaria A, Specchia G, Albano F.

Int J Mol Sci. 2018 Apr 11;19(4). pii: E1152. doi: 10.3390/ijms19041152. Review.

13.

Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia.

Coccaro N, Anelli L, Zagaria A, Casieri P, Tota G, Orsini P, Impera L, Minervini A, Minervini CF, Cumbo C, Parciante E, Carluccio P, Brunetti C, Specchia G, Albano F.

J Mol Diagn. 2018 Jul;20(4):474-482. doi: 10.1016/j.jmoldx.2018.03.002. Epub 2018 Apr 3.

14.

Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients.

Cumbo C, Impera L, Minervini CF, Orsini P, Anelli L, Zagaria A, Coccaro N, Tota G, Minervini A, Casieri P, Brunetti C, Rossi AR, Parciante E, Specchia G, Albano F.

Oncotarget. 2018 Jan 5;9(13):10978-10986. doi: 10.18632/oncotarget.23971. eCollection 2018 Feb 16.

15.

RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia.

Coccaro N, Zagaria A, Orsini P, Anelli L, Tota G, Casieri P, Impera L, Minervini A, Minervini CF, Cumbo C, Parciante E, Mestice A, Delia M, Brunetti C, Specchia G, Albano F.

Hum Pathol. 2018 Oct;80:82-86. doi: 10.1016/j.humpath.2018.02.023. Epub 2018 Mar 10.

PMID:
29530751
16.

SETBP1 dysregulation in congenital disorders and myeloid neoplasms.

Coccaro N, Tota G, Zagaria A, Anelli L, Specchia G, Albano F.

Oncotarget. 2017 Apr 19;8(31):51920-51935. doi: 10.18632/oncotarget.17231. eCollection 2017 Aug 1. Review.

17.

CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?

Brunetti C, Anelli L, Zagaria A, Specchia G, Albano F.

Expert Rev Hematol. 2017 Oct;10(10):853-862. doi: 10.1080/17474086.2017.1369400. Epub 2017 Aug 24. Review.

PMID:
28814164
18.

A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome.

Coccaro N, Brunetti C, Tota G, Pierri CL, Anelli L, Zagaria A, Casieri P, Impera L, Minervini CF, Minervini A, Cumbo C, Ricco A, Carluccio P, Orsini P, Specchia G, Albano F.

Leuk Lymphoma. 2018 Apr;59(4):996-999. doi: 10.1080/10428194.2017.1352093. Epub 2017 Jul 18. No abstract available.

PMID:
28718702
19.

Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology.

Minervini CF, Cumbo C, Orsini P, Anelli L, Zagaria A, Impera L, Coccaro N, Brunetti C, Minervini A, Casieri P, Tota G, Russo Rossi A, Specchia G, Albano F.

Exp Mol Pathol. 2017 Aug;103(1):33-37. doi: 10.1016/j.yexmp.2017.06.007. Epub 2017 Jun 27.

PMID:
28663031
20.

Monosomal karyotype in myeloid neoplasias: a literature review.

Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F.

Onco Targets Ther. 2017 Apr 20;10:2163-2171. doi: 10.2147/OTT.S133937. eCollection 2017. Review.

21.

Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?

Zagaria A, Anelli L, Coccaro N, Tota G, Brunetti C, Minervini A, Casieri P, Impera L, Minervini CF, Giordano A, Orsini P, Cumbo C, Specchia G, Albano F.

Turk J Haematol. 2017 Aug 2;34(3):276-277. doi: 10.4274/tjh.2017.0014. Epub 2017 Mar 29. No abstract available.

22.

Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia.

Brunetti C, Anelli L, Zagaria A, Minervini A, Minervini CF, Casieri P, Coccaro N, Cumbo C, Tota G, Impera L, Orsini P, Specchia G, Albano F.

J Mol Diagn. 2017 May;19(3):437-444. doi: 10.1016/j.jmoldx.2017.01.004. Epub 2017 Mar 6.

23.

Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia.

Minervini A, Francesco Minervini C, Anelli L, Zagaria A, Casieri P, Coccaro N, Cumbo C, Tota G, Impera L, Orsini P, Brunetti C, Giordano A, Specchia G, Albano F.

Oncotarget. 2016 Dec 27;7(52):86469-86479. doi: 10.18632/oncotarget.13246.

24.

TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.

Minervini CF, Cumbo C, Orsini P, Brunetti C, Anelli L, Zagaria A, Minervini A, Casieri P, Coccaro N, Tota G, Impera L, Giordano A, Specchia G, Albano F.

Diagn Pathol. 2016 Oct 10;11(1):96.

25.

MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32).

Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, Minervini CF, Minervini A, Cumbo C, Impera L, Brunetti C, Orsini P, Parciante E, Mestice A, Specchia G, Albano F.

Oncol Lett. 2016 Aug;12(2):1460-1464. Epub 2016 Jun 22.

26.

New occurrences of fossilized feathers: systematics and taphonomy of the Santana Formation of the Araripe Basin (Cretaceous), NE, Brazil.

Prado GM, Anelli LE, Petri S, Romero GR.

PeerJ. 2016 Jul 7;4:e1916. doi: 10.7717/peerj.1916. eCollection 2016.

27.

Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms.

Anelli L, Zagaria A, Coccaro N, Tota G, Minervini A, Casieri P, Impera L, Minervini CF, Brunetti C, Ricco A, Orsini P, Cumbo C, Specchia G, Albano F.

Ann Hematol. 2016 Sep;95(9):1559-60. doi: 10.1007/s00277-016-2739-2. Epub 2016 Jul 1. No abstract available.

PMID:
27365140
28.

Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3.

Coccaro N, Zagaria A, Tota G, Anelli L, Orsini P, Casieri P, Cellamare A, Minervini A, Impera L, Minervini CF, Brunetti C, Mestice A, Carluccio P, Cumbo C, Specchia G, Albano F.

Cancer Genet. 2015 Oct;208(10):517-22. doi: 10.1016/j.cancergen.2015.07.006. Epub 2015 Aug 4.

PMID:
26345353
29.

BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.

Zagaria A, Anelli L, Coccaro N, Tota G, Casieri P, Cellamare A, Impera L, Brunetti C, Minervini A, Minervini CF, Delia M, Cumbo C, Orsini P, Specchia G, Albano F.

Virchows Arch. 2015 Sep;467(3):357-63. doi: 10.1007/s00428-015-1802-z. Epub 2015 Jul 7.

PMID:
26149409
30.

Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia.

Albano F, Zagaria A, Anelli L, Coccaro N, Tota G, Brunetti C, Minervini CF, Impera L, Minervini A, Cellamare A, Orsini P, Cumbo C, Casieri P, Specchia G.

Oncotarget. 2015 May 30;6(15):13269-77.

31.

ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia.

Tota G, Coccaro N, Zagaria A, Anelli L, Casieri P, Cellamare A, Minervini A, Minervini CF, Brunetti C, Impera L, Carluccio P, Cumbo C, Specchia G, Albano F.

BMC Cancer. 2014 Dec 16;14:963. doi: 10.1186/1471-2407-14-963.

32.

5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications.

Zagaria A, Anelli L, Coccaro N, Tota G, Casieri P, Cellamare A, Minervini A, Minervini CF, Brunetti C, Cumbo C, Specchia G, Albano F.

Mol Cytogenet. 2014 Oct 1;7(1):66. doi: 10.1186/s13039-014-0066-7. eCollection 2014.

33.

Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P.

Zagaria A, Coccaro N, Tota G, Anelli L, Minervini A, Casieri P, Cellamare A, Minervini CF, Brunetti C, Ricco A, Orsini P, Cumbo C, Specchia G, Albano F.

Blood Cells Mol Dis. 2015 Jan;54(1):51-2. doi: 10.1016/j.bcmd.2014.07.022. Epub 2014 Aug 20.

PMID:
25159121
34.

Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with the SET binding protein 1 gene mutation.

Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, Minervini A, Minervini CF, Brunetti C, Ricco A, Orsini P, Cumbo C, Specchia G, Albano F.

Leuk Lymphoma. 2015 Mar;56(3):826-8. doi: 10.3109/10428194.2014.939968. Epub 2014 Aug 4. No abstract available.

PMID:
24991718
35.

IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.

Anelli L, Zagaria A, Minervini A, Casieri P, Coccaro N, Tota G, Minervini CF, Brunetti C, Impera L, Ricco A, Cellamare A, Specchia G, Albano F.

Ann Hematol. 2014 Sep;93(9):1605-7. doi: 10.1007/s00277-013-2004-x. Epub 2014 Jan 10. No abstract available.

PMID:
24408161
36.

Lymphoid enhancer binding factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia.

Albano F, Zagaria A, Anelli L, Orsini P, Minervini CF, Impera L, Casieri P, Coccaro N, Tota G, Brunetti C, Minervini A, Pastore D, Carluccio P, Mestice A, Cellamare A, Specchia G.

Oncotarget. 2014 Feb 15;5(3):649-58.

37.

Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.

Albano F, Anelli L, Zagaria A, Coccaro N, Tota G, Impera L, Minervini CF, Cellamare A, Delia M, Minervini A, Casieri P, Specchia G.

Hum Pathol. 2014 Mar;45(3):643-7. doi: 10.1016/j.humpath.2013.09.013. Epub 2013 Oct 3.

PMID:
24342433
38.

BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation?

Zagaria A, Anelli L, Casieri P, Coccaro N, Tota G, Minervini CF, Minervini A, Impera L, Brunetti C, Orsini P, Cellamare A, Specchia G, Albano F.

Leuk Lymphoma. 2014 Sep;55(9):2199-201. doi: 10.3109/10428194.2013.874009. Epub 2014 Feb 24. No abstract available.

PMID:
24325634
39.

A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia.

Anelli L, Zagaria A, Coccaro N, Tota G, Impera L, Minervini CF, Pastore D, Minervini A, Casieri P, Specchia G, Albano F.

Gene. 2013 Oct 15;529(1):144-7. doi: 10.1016/j.gene.2013.07.105. Epub 2013 Aug 9.

PMID:
23933272
40.

Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation.

Albano F, Zagaria A, Anelli L, Coccaro N, Impera L, Minervini CF, Minervini A, Rossi AR, Tota G, Casieri P, Specchia G.

Mol Cancer. 2013 May 4;12:36. doi: 10.1186/1476-4598-12-36.

41.

SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia.

Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Minervini A, Specchia G.

J Hematol Oncol. 2012 Aug 8;5:48. doi: 10.1186/1756-8722-5-48.

42.

A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene.

Zagaria A, Anelli L, Coccaro N, Casieri P, Minervini A, Buttiglione V, Ricco A, Specchia G, Albano F.

Leuk Res. 2012 Jul;36(7):852-6. doi: 10.1016/j.leukres.2012.01.026. Epub 2012 Feb 25.

PMID:
22365942
43.

Decreased TET2 gene expression during chronic myeloid leukemia progression.

Albano F, Anelli L, Zagaria A, Coccaro N, Minervini A, Rossi AR, Specchia G.

Leuk Res. 2011 Nov;35(11):e220-2. doi: 10.1016/j.leukres.2011.07.013. Epub 2011 Jul 27.

PMID:
21794915
44.

Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.

Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Rossi AR, Vicari L, Liso V, Rocchi M, Specchia G.

Mol Cancer. 2010 May 25;9:120. doi: 10.1186/1476-4598-9-120.

45.

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia.

Albano F, Anelli L, Zagaria A, Coccaro N, D'Addabbo P, Liso V, Rocchi M, Specchia G.

Oncogene. 2010 Apr 29;29(17):2509-16. doi: 10.1038/onc.2009.524. Epub 2010 Jan 25.

PMID:
20101201
46.

MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9).

Albano F, Anelli L, Zagaria A, Liso V, Rocchi M, Specchia G.

Br J Haematol. 2009 Jan;144(2):271-3. doi: 10.1111/j.1365-2141.2008.07459.x. Epub 2008 Nov 19. No abstract available.

PMID:
19036106
47.

Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9).

Albano F, Anelli L, Zagaria A, Pannunzio A, Liso V, Rocchi M, Specchia G.

Leukemia. 2009 Apr;23(4):813-6. doi: 10.1038/leu.2008.311. Epub 2008 Nov 6. No abstract available.

PMID:
18987658
48.

The double deceit generated by an insertion mechanism in chronic myeloid leukemia with t(9;9;22).

Albano F, Zagaria A, Anelli L, Pannunzio A, Manodoro F, Coccaro N, Russo Rossi A, Liso V, Rocchi M, Specchia G.

Ann Hematol. 2008 Nov;87(11):923-6. doi: 10.1007/s00277-008-0511-y. Epub 2008 Jun 14. No abstract available.

PMID:
18553081
49.

Genomic and molecular switching in relapsed acute promyelocytic leukemia.

Albano F, Pannunzio A, Anelli L, Zagaria A, Liso V, Rocchi M, Specchia G.

Leukemia. 2008 Jul;22(7):1469-72. doi: 10.1038/sj.leu.2405103. Epub 2008 Feb 7. No abstract available.

PMID:
18256686
50.

Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia.

Albano F, Anelli L, Zagaria A, Lonoce A, La Starza R, Liso V, Rocchi M, Specchia G.

Leuk Res. 2008 Feb;32(2):347-51. Epub 2007 Aug 2.

PMID:
17681599

Supplemental Content

Loading ...
Support Center